Literature DB >> 8343289

A pilot study of vinorelbine on a weekly schedule in recurrent and/or metastatic squamous cell carcinoma of the head and neck.

V Gebbia, A Testa, R Valenza, G Zerillo, S Restivo, F Ingria, G Cannata, N Gebbia.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8343289     DOI： 10.1016/0959-8049(93)90095-w

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN： 0959-8049            Impact factor:   9.162


× No keyword cloud information.
  5 in total

Review 1.  Head and neck cancer: guidelines for chemotherapy.

Authors:  G Catimel
Journal:  Drugs       Date:  1996-01       Impact factor: 9.546

2.  A phase I and pharmacokinetic study of liposomal vinorelbine in patients with advanced solid tumor.

Authors:  Shih-Hung Yang; Chia-Chi Lin; Zhong-Zhe Lin; Yun-Long Tseng; Ruey-Long Hong
Journal:  Invest New Drugs       Date:  2010-09-01       Impact factor: 3.850

Review 3.  Vinorelbine. A review of its pharmacological properties and clinical use in cancer chemotherapy.

Authors:  K L Goa; D Faulds
Journal:  Drugs Aging       Date:  1994-09       Impact factor: 3.923

4.  Vinorelbine in pre-treated advanced head & neck squamous cell carcinoma. A phase II study.

Authors:  A Testolin; G Recher; V Cristoferi; G Gasparini
Journal:  Invest New Drugs       Date:  1994       Impact factor: 3.850

Review 5.  A phase II study of docetaxel in patients with metastatic squamous cell carcinoma of the head and neck.

Authors:  C Couteau; N Chouaki; S Leyvraz; D Oulid-Aissa; A Lebecq; C Domenge; V Groult; S Bordessoule; F Janot; M De Forni; J P Armand
Journal:  Br J Cancer       Date:  1999-10       Impact factor: 7.640
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.